Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

CNS 3

Conditions

Brain Neoplasms 405Glioma 261Glioblastoma 204Central Nervous System Neoplasms 92Neoplasms 87Neuroblastoma 82Astrocytoma 72Neurofibromatosis 1 55Breast Neoplasms 52Meningioma 51Lung Neoplasms 42Oligodendroglioma 39Head and Neck Neoplasms 35Medulloblastoma 33Spinal Cord Neoplasms 30Sarcoma 30Leukemia 30Paraganglioma 29Pheochromocytoma 28Lymphoma 28Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 24Neuroma, Acoustic 24Ependymoma 24Melanoma 22Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Ovarian Neoplasms 20Neoplasm Metastasis 19Lymphoma, Non-Hodgkin 19

Interventions

Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Hemangioma, Cavernous × CNS × Clear all
NCT04467489 2025-08-11

Biomarkers of CASH

University of Chicago

Active not recruiting
1,040 enrolled
CNS

Hemangioma, Cavernous, Hemangioma, Cavernous, Central Nervous System

NCT03652181 2024-06-27

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

University of Chicago

Completed
123 enrolled 27 charts
CNS

Cerebral Cavernous Malformations 3, Cerebral Cavernous Malformations 2, Hemangioma, Cavernous, Hemangioma, Capillary, Hemangioma, Cavernous, Central Nervous System

NCT04076449 2019-09-04

CRESS

Beijing Tiantan Hospital

Recruiting
200 enrolled
CNS

Epilepsy, Hemangioma, Cavernous, Seizures, Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon âš¡